scispace - formally typeset
A

Alessandro Bernasconi

Researcher at Vita-Salute San Raffaele University

Publications -  16
Citations -  1291

Alessandro Bernasconi is an academic researcher from Vita-Salute San Raffaele University. The author has contributed to research in topics: Bipolar disorder & Sleep deprivation. The author has an hindex of 13, co-authored 16 publications receiving 1227 citations.

Papers
More filters
Journal ArticleDOI

Long-term response to lithium salts in bipolar illness is influenced by the glycogen synthase kinase 3-β −50 T/C SNP

TL;DR: Results showed that homozygotes for the wild variant did not change their recurrence index while carriers of the mutant allele improved, thus supporting the hypothesis that GSK is a target for the therapeutic action of lithium.
Journal ArticleDOI

A single nucleotide polymorphism in glycogen synthase kinase 3-β promoter gene influences onset of illness in patients affected by bipolar disorder

TL;DR: Results warrant interest for the variants of genes pertaining to the molecular clock as possible endophenotypes of bipolar disorder, but caution ought to be taken in interpreting these preliminary results and future replication studies must be awaited.
Journal ArticleDOI

Functional and structural brain correlates of theory of mind and empathy deficits in schizophrenia

TL;DR: Functional and structural abnormalities were observed in areas affected by the schizophrenic process early in the illness course, and known to be crucial for social cognition, suggesting a biological basis forSocial cognition deficits in schizophrenia.
Journal ArticleDOI

Dark therapy for mania: a pilot study.

TL;DR: Adding DT to TAU resulted in a significantly faster decrease of YMRS scores when patients were treated within 2 weeks from the onset of the current manic episode, and Chronobiological interventions and control of environmental stimuli can be a useful add-on for the treatment of acute mania in a hospital setting.
Journal ArticleDOI

Morning light treatment hastens the antidepressant effect of citalopram: a placebo-controlled trial.

TL;DR: With an optimized timing of administration, low-intensity light treatment significantly hastened and potentiated the effect of citalopram, thus providing the clinical psychiatrists with an augmenting strategy that was found effective and devoid of side effects.